What does CUSIP 019770106 represent in this 13F holders report?

CUSIP 019770106 is the security identifier for ALLO - Allogene Therapeutics, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held ALLO - Allogene Therapeutics, Inc. - Common Stock in Q1 2026?

208 institutional investors reported ALLO - Allogene Therapeutics, Inc. - Common Stock for Q1 2026. Use the holders table for investor-level position and value details.

Allogene Therapeutics, Inc. - Common Stock (ALLO)

CUSIP: 019770106

Q1 2026 13F Holders as of 31 Mar 2026

Security type / class: Equity / Common Stock
Total 13F shares: 184,187,050
Total 13F value: $444,742,093
Share change: +21,752,090
Put/Call ratio: 44%
SEC-reported price per share: $2.44
Number of holders: 208
Value change: +$59,358,082
Number of buys: 126
Number of sells: 52
Shares outstanding: 348,989,179

Security key

019770106

Report period

Q1 2026

Institutions

208

Top holders

ALLO full security history Ownership snapshot Full 13F holder table Allogene Therapeutics, Inc. SEC filings Allogene Therapeutics, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of ALLO - Allogene Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

PFIZER INC

Disclosed value leader

TPG GP A, LLC

Comparable rows

15/15

Latest evidence

31 Mar 2026

13F 13D/G 3/4/5 Lead comparable stake: 9% 13D/G row: PFIZER INC Showing 1-6 of 15 holder rows.

Quick read

PFIZER INC leads the comparable SEC ownership view at 9%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens PFIZER INC's linked filing trail.

Comparable ownership Top 5

PFIZER INC 9%

BlackRock, Inc. 5.3%

David D. Chang 4.9%

FMR LLC 4.9%

CITADEL ADVISORS LLC 2.8%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
PFIZER INC	13F 13D/G Company 13F 13D/G	9% from 13D/G	$30,183,895 22,032,040 shares	—	31 Dec 2025
BlackRock, Inc.	13F 13D/G Company 13F 13D/G	5.3% from 13D/G	$24,216,160 17,676,029 shares	—	31 Dec 2025
David D. Chang	13D/G 3/4/5 David D. Chang, M.D., Ph.D. · President and CEO, Director 13D/G 3/4/5	4.9%	$30,005,544 12,297,354 shares	+$478,560	31 Mar 2026
FMR LLC	13D/G 13F Company 13D/G 13F	4.9%	$15,747,811 10,225,851 shares	-$20,861,062	28 Feb 2025
CITADEL ADVISORS LLC	13D/G 13F Kenneth Griffin · Company 13D/G 13F	2.8%	$16,726,493 6,855,120 shares	-$15,838,116	31 Mar 2026
TPG GP A, LLC	3/4/5 13F 10%+ Owner · Company 3/4/5 13F	5.4% from 13F	$59,413,042 18,716,306 shares	—	12 Jan 2022

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

208

184,187,050

Rows available

208

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2026 vs Q1 2026 Across Filers

Q1 2026 holders

208

Q1 2026 holders

208

Holder diff

Investor	Q1 2026 Shares	Q1 2026 Shares	Share Diff	Share Chg %	Q1 2026 value	Q1 2026 value	Value change	Value Chg %